OKYO Pharma (OKYO) Shares Outstanding (Entity) (2021 - 2022)
OKYO Pharma's Shares Outstanding (Entity) came in at 979.21 million for the quarter ended Mar 31, 2022, up 45.5% from 672.77 million a year earlier.
Powered by 
Analysis
OKYO Pharma (OKYO) Shares Outstanding (Entity) (2021 - 2022) Analysis & Trends
- Going back by year, Shares Outstanding (Entity) was 672.77 million in the year ended Mar 31, 2021 (+13.0%) and 595.47 million in the year ended Mar 31, 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.70 Bn |
| 10 | OKYO Pharma | 1.37 Bn | 1.34 Bn | - | - |
API Access
OKYO Pharma Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=OKYO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "OKYO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=OKYO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();